Grace Therapeutics, Inc. (GRCE) — Cash Flow Quality Index

Latest as of March 2025: -4.64x

Grace Therapeutics, Inc. (GRCE) has a Cash Flow Quality Index of -4.64x as of March 2025. Operating cash flow of $-2.95 Million is below net income of $636.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore how well can Grace Therapeutics, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.64x

Operating CF / Net Income

Operating Cash Flow

$-2.95 Million

USD

Net Income

$636.00K

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Grace Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Grace Therapeutics, Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.